Research & Development

Unlocking Cancer Therapy: Overcoming Hypoxia-Induced Resistance
Research & Development Unlocking Cancer Therapy: Overcoming Hypoxia-Induced Resistance

Advancements in cancer therapy have brought significant hope, especially with immune checkpoint blockades (ICBs), providing a groundbreaking treatment strategy for advanced cancers. Despite this, the effectiveness of ICBs has often been thwarted by therapeutic resistance, which renders

USC Awarded $3.4M to Tackle Cognitive Decline in Aging Women
Research & Development USC Awarded $3.4M to Tackle Cognitive Decline in Aging Women

The Keck School of Medicine of USC has embarked on a groundbreaking research initiative aimed at addressing age-related cognitive decline in women. This significant effort is led by Dr. Young-Kwon Hong and has been bolstered by securing a $3.4 million federal grant from the Advanced Research

Can Innovative Tech Improve Long-Term Outcomes in Pediatric AE?
Research & Development Can Innovative Tech Improve Long-Term Outcomes in Pediatric AE?

Autoimmune encephalitis (AE), a condition where the body's immune system turns against the brain, affects approximately one-third of global encephalitis cases and often leads to debilitating symptoms, including seizures, cognitive impairment, and motor dysfunctions. Despite advancements in

Global Trends in Ovarian Cancer Incidence and Histological Subtypes Analysis
Research & Development Global Trends in Ovarian Cancer Incidence and Histological Subtypes Analysis

Ovarian cancer represents a significant health concern worldwide, being the eighth most frequently diagnosed cancer and the leading cause of cancer-related mortality among women globally. In 2022 alone, the disease accounted for over 324,000 new cases and 206,839 deaths across the globe. This

How Will New HIV Guidelines Change Treatment and Prevention?
Research & Development How Will New HIV Guidelines Change Treatment and Prevention?

The International Antiviral (formerly AIDS) Society-USA (IAS-USA) has unveiled comprehensive international guidelines for the treatment and prevention of HIV, coinciding with the observance of World AIDS Day on December 1, 2024. These guidelines were meticulously developed by a panel of volunteer

Can GLP-1 Receptor Agonists Transform MASLD Treatment Effectiveness?
Research & Development Can GLP-1 Receptor Agonists Transform MASLD Treatment Effectiveness?

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), previously known as nonalcoholic fatty liver disease, has become a major global health concern. Characterized by hepatic steatosis and associated with at least one cardiometabolic risk factor such as type 2 diabetes mellitus (T2DM),

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later